The Effect of a High-Fat Meal on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers
Clinical Pharmacology in Drug Development - United States
doi 10.1002/cpdd.641
Full Text
Open PDFAbstract
Available in full text
Date
December 20, 2018
Authors
Publisher
Wiley